Carregant...

Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia

Since December 2019, a novel coronavirus pneumonia (COVID-19) has broken out in Wuhan, China and spread rapidly. Recent studies have found that ⁓ 15.7% of patients develop severe pneumonia, and cytokine storm is an important factor leading to rapid disease progression. Currently, there are no specif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Drug Investig
Autors principals: Zhang, Shengyu, Li, Lei, Shen, Aizong, Chen, Yongwu, Qi, Zhigang
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7183818/
https://ncbi.nlm.nih.gov/pubmed/32337664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-020-00917-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!